144 related articles for article (PubMed ID: 28449818)
1. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
[TBL] [Abstract][Full Text] [Related]
2. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
3. AE1/AE3, vimentin and p63 immunolocalization in canine mammary gland tumours: roles in differentiation between luminal epithelial and myoepithelial lineages.
Toniti P; Sirivisoot S; Jandee P; Srimontri P; Puchadapirom P; Doungchawee G; Kasorndorkbua C
Asian Pac J Cancer Prev; 2010; 11(1):227-30. PubMed ID: 20593961
[TBL] [Abstract][Full Text] [Related]
4. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
[TBL] [Abstract][Full Text] [Related]
5. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumours and duct ectasias.
Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC
Vet Q; 1993 Sep; 15(3):89-95. PubMed ID: 7505510
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium.
Espinosa Los de Monteros A; Millán MY; Ordás J; Carrasco L; Reymundo C; Martín Las de Mulas J
Vet Pathol; 2002 Mar; 39(2):247-56. PubMed ID: 12009063
[TBL] [Abstract][Full Text] [Related]
9. Comparative pathology of canine mammary tumours.
Nerurkar VR; Chitale AR; Jalnapurkar BV; Naik SN; Lalitha VS
J Comp Pathol; 1989 Nov; 101(4):389-97. PubMed ID: 2558128
[TBL] [Abstract][Full Text] [Related]
10. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
Geraldes M; Gärtner F; Schmitt F
Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
[TBL] [Abstract][Full Text] [Related]
12. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
13. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.
Griffey SM; Madewell BR; Dairkee SH; Hunt JE; Naydan DK; Higgins RJ
Vet Pathol; 1993 Mar; 30(2):155-61. PubMed ID: 7682368
[TBL] [Abstract][Full Text] [Related]
15. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
18. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
[TBL] [Abstract][Full Text] [Related]
19. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
